Role of Ischemia Modified Albumin in Early Diagnosis of Acute Coronary Syndrome

LI Bing-bing,DONG Zhi-yuan,JIANG Shan,ZHOU Qi,DENG Lin-qi,CHENG Xi-wing,ZHAO Juan

DOI: https://doi.org/10.3969/j.issn.1000-2200.2011.05.006

2011-01-01

Abstract:Objective:To estimate the value of ischemia modified albumin(IMA) in early diagnosis of acute coronary syndrome(ACS).Methods:The venous blood samples from 56 patients with ACS(ACS group),30 patients with non-ischemia chest pain(NICP group) within 3 h of onset and 155 healthy controls were assayed,and the IMA,MB type creatine kinase(CK-MB) and cardiac troponin(cTnI) levels were compared among the three groups.The value of the myocardial markers in early diagnosis of ACS was estimated by the ROC curve.Results:The IMA of the 3 groups were(0.500±0.017),(0.400±0.082) and(0.326±0.024) absorbance unit,respectively;the serum level of IMA in ACS group was higher than that in healthy controls and NICP group(P0.01).The area under curve of IMA was larger than that of cTnI and CK-MB;the sensitivity of IMA was higher than that of CK-MB and cTnI;the specificity of IMA was more obvious than that of cTnICK-MB.The best cutoff value of IMA,CK-MB and cTnI was definite.Compared with the NICP group,the positive likelihood ratio and negative likelihood ratio of IMA for ACS were 10.7 and 0.008,respectively;compared with the healthy controls,the positive likelihood ratio and negative likelihood ratio of IMA for ACS were 8.23 and 0.013,respectively.Conclusions:IMA is superior to cTnI and CK-MB in diagnostic of ACS at the early stage.